HEMORRHAGE INCREASES CYTOKINE EXPRESSION IN LUNG MONONUCLEAR-CELLS INMICE - INVOLVEMENT OF CATECHOLAMINES IN NUCLEAR FACTOR-KAPPA-B REGULATION AND CYTOKINE EXPRESSION
Y. Letulzo et al., HEMORRHAGE INCREASES CYTOKINE EXPRESSION IN LUNG MONONUCLEAR-CELLS INMICE - INVOLVEMENT OF CATECHOLAMINES IN NUCLEAR FACTOR-KAPPA-B REGULATION AND CYTOKINE EXPRESSION, The Journal of clinical investigation, 99(7), 1997, pp. 1516-1524
The expression of proinflammatory and immunoregulatory cytokines rapid
ly increases in the lungs after hemorrhage, and such alterations contr
ibute to the frequent development of acute inflammatory lung injury in
this setting. Blood loss also produces elevations in catecholamine co
ncentrations in the pulmonary and systemic circulation, In the present
experiments, we used alpha- and beta-adrenergic receptor blockade to
examine in vivo interactions between hemorrhage-induced adrenergic sti
mulation and pulmonary cytokine expression, Treatment of mice with the
alpha-adrenergic receptor antagonist phentolamine prevented not only
the elevation in mRNA levels of IL-1 beta, TNF-alpha, and TGF-beta 1,
the increase in IL-1 beta protein, but also the activation of nuclear
factor (NF)-kappa B and cyclic AMP response element binding protein, w
hich occurred in lung cells of untreated animals during the first hour
after hemorrhage. in contrast, treatment before hemorrhage with the b
eta-adrenergic receptor antagonist propranolol was associated with inc
reases in mRNA levels for IL-1 beta, TNF-alpha, and TGF-beta 1, which
were greater than those present in untreated hemorrhaged mice, and did
mot prevent hemorrhage-associated increases in lung IL-1 beta protein
, Treatment with propranolol prevented hemorrhage-induced phosphorylat
ion of cyclic AMP response element binding protein, but increased hemo
rrhage-associated activation of NF-kappa B. These results demonstrate
that hemorrhage initially increases pulmonary cytokine expression thro
ugh alpha- but not beta-adrenergic stimulation, and suggest that such
alpha-adrenergic-mediated effects occur through activation of the tran
scriptional regulatory factor NF-kappa B.